
Eos SENOLYTIX, a Longevity Medicine Company, Announces the Appointment of Brent Saunders as Advisory Board Chairman
• Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 MIAMI, FL, UNITED STATES, February 26, 2025 /EINPresswire.com/ -- Eos SENOLYTIX, Inc., a …